ENOKIZUMAB
UNII I4BE5F78HR

Substance Identification & Data

This profile provides standardized clinical and technical data for Enokizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I4BE5F78HR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 909875-08-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

I4BE5F78HR

CAS Registry Number

909875-08-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ENOKIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C97929

National Cancer Institute reference terminology for clinical and research data.

INN ID

9262

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-131

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enokizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENOKIZUMAB

Common Names & Synonyms

7F3COM2H2

ENOKIZUMAB [INN]

ENOKIZUMAB [USAN]

ENOKIZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 9) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI-528 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI-528 .KAPPA.-CHAIN, DIMER